Clinical Data Presented at the European Congress on Obesity 2022 Demonstrates Weight Loss With GS200 in Adults With Prediabetes and Type 2 Diabetes
BOSTON--(BUSINESS WIRE)--Gelesis (NYSE: GLS), a consumer-focused biotherapeutics firm and the maker of Plenity®, at this ...
Read more